BioAtla procures $72.5m Series D

San Diego and China-based BioAtla Inc, a clinical-stage biotechnology company, has raised $72.5 million in Series D financing.

16 July 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles